MICHAEL FICHTER: Open Payments
NPI 1215116652 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 73 payments from 15 companies in 2025. Trend: 2023 $438 · 2024 $1,827 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 32 | $160 |
| Merck Sharp & Dohme LLC | 7 | $151 |
| Alnylam Pharmaceuticals Inc. | 4 | $141 |
| Amgen Inc. | 5 | $124 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $119 |
| Novo Nordisk Inc | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Stryker Corporation | 1 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Abbott Laboratories | 1 | $32 |
Products named: LEQVIO, VERQUVO, REPATHA, LifeVest, ONPATTRO, AMVUTTRA, Kerendia, FLOWTRIEVER CATHETER, S.
Industry payments across TX — which companies pay providers there.
